Kytril, Konzentrat zur Herstellung einer Infusionslösung 3 mg

7680511980423 CH-51198 Konzentrat
Kytril, Konzentrat zur Herstellung einer Infusionslösung 3 mg
Kytril, Konzentrat zur Herstellung einer Infusionslösung 3 mg
Kytril, Konzentrat zur Herstellung einer Infusionslösung 3 mg
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Ampulle(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/12/2023
Summary of Product Characteristics
Français
05/12/2023
Summary of Product Characteristics
Italien
05/12/2023

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
12.5 MG Substance HBESI

Reimbursement information

Public price
CHF 101.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1994

Authorization holder

Atnahs Pharma Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
51198
Drug name
Kytril, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
A04AA02
Authorization status
Z
Dispensing category
B
First authorization
09/10/1991
Authorization expiration date
31/12/9999
IT Number
01.09.0.
Domain
Human medicine
Field of application
Antiemetikum

Package details

Description (FR)
KYTRIL conc perf 3 mg/3ml 5 amp 3 ml
Description (DE)
KYTRIL Inf Konz 3 mg/3ml 5 Amp 3 ml
Market launch
09/10/1991
Narcotic (BTM)
No

Available generics (2)

Granisetron Fresenius i.v., Infusionskonzentrat
GTIN: 7680650500018
CHF 47.90
View
Granisetron Fresenius i.v., Infusionskonzentrat
GTIN: 7680650500032
CHF 88.90
View

Other package sizes (3)

None
5 AMP
GTIN: None
Not in V1
None
5 AMP
GTIN: None
Not in V1
KYTRIL conc perf 1 mg/ml 5 amp 1 ml
5 AMP
GTIN: 7680511980348
View